AmerX, a global broker–dealer and self–clearing firm operating as one of the largest members on the floor of the New York Stock Exchange, today announced the addition of its equity research—marking a ...

Beyer is an M.D./Ph.D. candidate at Harvard Medical School and the Harvard T. H. Chan School of Public Health. As a pediatrician and a scientist-in-training, I conduct research on a critical question ...

When major stock market indices, such as the S&P 500 (SPX), trend down, investors applying a broad market approach to investing may want to shift to tailoring more selective portfolios. The goal would ...

The impact of a big shake-up coming to sell side research, as a result of regulatory changes in Europe, will cause research to become more expensive for both banks and asset managers worldwide — but ...

Stephens today announced that Bascome Majors has joined the firm’s institutional equity research practice as a Managing ...

Historically, the ability to conduct research has been limited to those with power, privilege, and resources. While grantmaking provides significant resources to fund research, those resources have ...

It was another rollercoaster year in the equity markets. Investors wanted just one thing from sell-side research in 2021: more. “There was a lot going on in the world, and the buy side continues to ...

Investment analysis involves synthesizing large amounts of text, video, and audio. The use of AI enables financial professionals to expand the universe of data that they can incorporate into their ...

Learn everything you need to know about T. Rowe Price US Equity Research ETF (TSPA) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it ...

Business Insider is seeking nominations for the top equity research analysts who are 35 and under. We want to hear from you about people who have stood out in the world of sell-side equity research.

Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer–Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial ASCO strives, through ...

Insider selected 19 research analysts 35 and under for its 2021 rising-stars list. We asked the up-and-comers to give us their best career advice for those just starting out. Here are some of the top ...